Cas no 23586-96-1 ((5-fluoro-3-pyridyl)methanamine)
(5-fluoro-3-pyridyl)methanamine Chemical and Physical Properties
Names and Identifiers
-
- 3-Aminomethyl-5-fluoropyridine
- (5-Fluoropyridin-3-yl)methanamine
- -(5-fluoro-pyridin-3yl)-methylamine
- (5-Fluoropyridin-3-yl)methylamine
- 3-Pyridinemethanamine,5-fluoro-
- 3-Aminomethyl-5-fluorpyridin
- 3-Pyridinemethanamine,5-fluoro
- 5-Fluor-3-aminomethylpyridin
- C-(5-fluoro-pyridin-3yl)-methylamine
- 3-Pyridinemethanamine, 5-fluoro-
- 3-Aminomethyl-5-fluoro-pyridine
- RYICOVXDBBDCNT-UHFFFAOYSA-N
- 3-(Aminomethyl)-5-fluoropyridine
- (5-fluoro-3-pyridinyl)methanamine
- (5-fluoranylpyridin-3-yl)methanamine
- 5-FLUORO-3-PYRIDINEMETHANAMINE
- PB29533
- RP09524
- KS
- (5-fluoro-3-pyridyl)methanamine
- SCHEMBL164566
- AMY12117
- AC-28895
- EN300-313127
- 23586-96-1
- 1-(5-FLUOROPYRIDIN-3-YL)METHANAMINE
- A816783
- AKOS005258856
- CS-W005699
- MFCD08450424
- DTXSID70668414
- YAA58696
- W-206832
- AS-34079
- SY023017
- FT-0685927
- 3-Pyridinemethanamine,5-fluoro-(9CI)
-
- MDL: MFCD08450424
- Inchi: 1S/C6H7FN2/c7-6-1-5(2-8)3-9-4-6/h1,3-4H,2,8H2
- InChI Key: RYICOVXDBBDCNT-UHFFFAOYSA-N
- SMILES: FC1=CN=CC(=C1)CN
Computed Properties
- Exact Mass: 126.05900
- Monoisotopic Mass: 126.05932639g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 9
- Rotatable Bond Count: 1
- Complexity: 87.1
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Surface Charge: 0
- Tautomer Count: nothing
- XLogP3: -0.2
- Topological Polar Surface Area: 38.9
Experimental Properties
- PSA: 38.91000
- LogP: 1.37970
(5-fluoro-3-pyridyl)methanamine Customs Data
- HS CODE:2933399090
- Customs Data:
China Customs Code:
2933399090Overview:
2933399090. Other compounds with non fused pyridine rings in structure. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%
Declaration elements:
Product Name, component content, use to, Please indicate the appearance of Urotropine, 6- caprolactam please indicate the appearance, Signing date
Summary:
2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
(5-fluoro-3-pyridyl)methanamine Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Chemenu | CM107594-1g |
(5-fluoropyridin-3-yl)methanamine |
23586-96-1 | 97% | 1g |
$275 | 2021-08-06 | |
| Chemenu | CM107594-5g |
(5-fluoropyridin-3-yl)methanamine |
23586-96-1 | 97% | 5g |
$825 | 2021-08-06 | |
| Chemenu | CM107594-10g |
(5-fluoropyridin-3-yl)methanamine |
23586-96-1 | 97% | 10g |
$1375 | 2021-08-06 | |
| TRC | F594625-250mg |
(5-Fluoropyridin-3-yl)methylamine |
23586-96-1 | 250mg |
$184.00 | 2023-05-18 | ||
| TRC | F594625-500mg |
(5-Fluoropyridin-3-yl)methylamine |
23586-96-1 | 500mg |
$316.00 | 2023-05-18 | ||
| TRC | F594625-1g |
(5-Fluoropyridin-3-yl)methylamine |
23586-96-1 | 1g |
$ 375.00 | 2022-06-04 | ||
| TRC | F594625-2.5g |
(5-Fluoropyridin-3-yl)methylamine |
23586-96-1 | 2.5g |
$919.00 | 2023-05-18 | ||
| Chemenu | CM107594-250mg |
(5-fluoropyridin-3-yl)methanamine |
23586-96-1 | 97% | 250mg |
$112 | 2024-07-28 | |
| Chemenu | CM107594-1g |
(5-fluoropyridin-3-yl)methanamine |
23586-96-1 | 97% | 1g |
$216 | 2023-02-17 | |
| Chemenu | CM107594-5g |
(5-fluoropyridin-3-yl)methanamine |
23586-96-1 | 97% | 5g |
$679 | 2023-02-17 |
(5-fluoro-3-pyridyl)methanamine Related Literature
-
Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
-
Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
-
Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
-
Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755
-
Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
Additional information on (5-fluoro-3-pyridyl)methanamine
Chemical Profile of (5-fluoro-3-pyridyl)methanamine (CAS No. 23586-96-1)
(5-fluoro-3-pyridyl)methanamine, chemically identified by the CAS number 23586-96-1, is a significant compound in the realm of pharmaceutical and biochemical research. This heterocyclic amine features a pyridine core substituted with a fluorine atom at the 5-position and an amine group at the 3-position, linked to a methylene bridge. The structural configuration of this molecule imparts unique electronic and steric properties, making it a valuable scaffold for drug discovery and molecular design.
The presence of the fluorine atom in the pyridine ring is a critical feature that enhances the metabolic stability and binding affinity of the compound. Fluorinated pyridines are widely recognized in medicinal chemistry for their ability to modulate pharmacokinetic profiles, improve bioavailability, and increase receptor selectivity. This characteristic has positioned (5-fluoro-3-pyridyl)methanamine as a promising candidate for developing novel therapeutic agents targeting various biological pathways.
In recent years, researchers have been exploring the potential of (5-fluoro-3-pyridyl)methanamine in the development of small-molecule inhibitors for enzymes and receptors involved in cancer, inflammation, and neurodegenerative diseases. The compound's ability to interact with biological targets through its pyridine and amine functionalities has been leveraged to design molecules with enhanced potency and selectivity. For instance, studies have demonstrated its utility in inhibiting kinases and other enzymes that play pivotal roles in disease progression.
One of the most intriguing aspects of (5-fluoro-3-pyridyl)methanamine is its role as a building block in synthesizing more complex molecules. Its versatile structure allows for further functionalization, enabling chemists to create derivatives with tailored properties. This flexibility has been exploited in the synthesis of novel antiviral agents, where modifications to the fluoropyridine core have led to compounds with improved efficacy against viral infections.
The pharmacological activity of (5-fluoro-3-pyridyl)methanamine has been investigated in several preclinical studies. These studies have highlighted its potential as an intermediate in the development of drugs that modulate neurotransmitter systems. For example, derivatives of this compound have shown promise in treating conditions related to dopamine dysregulation, such as Parkinson's disease. The amine group at the 3-position provides a site for further chemical modification, allowing researchers to fine-tune the pharmacological profile of the molecule.
The synthesis of (5-fluoro-3-pyridyl)methanamine involves multi-step organic reactions that require precise control over reaction conditions. Advanced synthetic methodologies, including transition metal-catalyzed cross-coupling reactions and fluorination techniques, have been employed to achieve high yields and purity. These synthetic strategies not only enhance the accessibility of the compound but also provide insights into scalable production methods for related molecules.
Computational studies have also played a crucial role in understanding the behavior of (5-fluoro-3-pyridyl)methanamine at both molecular and cellular levels. Molecular dynamics simulations have been used to model its interactions with biological targets, providing valuable insights into binding mechanisms and potential drug-like properties. These computational approaches complement experimental data, offering a holistic view of the compound's pharmacological relevance.
The growing interest in fluorinated heterocycles has spurred innovation in synthetic chemistry, leading to new methodologies for introducing fluorine atoms into complex molecular frameworks. Techniques such as electrophilic aromatic substitution and metal-catalyzed fluorination have been refined to achieve regioselective modifications at specific positions within the pyridine ring. This progress has significantly contributed to the development of (5-fluoro-3-pyridyl)methanamine as a key intermediate in pharmaceutical research.
In conclusion, (5-fluoro-3-pyridyl)methanamine (CAS No. 23586-96-1) represents a fascinating compound with substantial potential in medicinal chemistry. Its unique structural features, combined with its versatility as a synthetic intermediate, make it an invaluable tool for drug discovery efforts targeting various diseases. As research continues to uncover new applications for this molecule, its significance in pharmaceutical development is expected to grow even further.
23586-96-1 ((5-fluoro-3-pyridyl)methanamine) Related Products
- 1378656-35-9((5-Fluoro-6-methylpyridin-3-YL)methanamine)
- 1956436-47-7((S)-1-(5-Fluoropyridin-3-yl)ethanamine hydrochloride)
- 407-21-6(3-Fluoro-5-methylpyridine)
- 1060802-39-2((5-fluoropyridin-3-yl)methyl(methyl)amine)
- 864263-69-4((5-fluoro-3-pyridyl)methanamine;hydrochloride)
- 1212854-34-6((1R)-1-(5-fluoro-3-pyridyl)ethanamine)
- 1095380-87-2(1-(5-fluoropyridin-3-yl)methylpiperazine)
- 1356110-47-8((5-(3-Fluorophenyl)pyridin-3-yl)methanamine)
- 1909288-54-5((1R)-1-(5-fluoropyridin-3-yl)ethan-1-amine dihydrochloride)
- 1073372-18-5(Bis((5-fluoropyridin-3-yl)methyl)amine)